Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-25

Clinical Trial Update: A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating 2-Iminobiotin in neonates with perinatal asphyxia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2-Iminobiotin

Snippet

Sponsor: Neurophyxia B.V. | Conditions: Perinatal Asphyxia | Phase 2 | Status: TERMINATED